Titre : Algie post-zona

Algie post-zona : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Algie post-zona : Questions médicales les plus fréquentes", "headline": "Algie post-zona : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Algie post-zona : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-13", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Algie post-zona" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Névralgie", "url": "https://questionsmedicales.fr/mesh/D009437", "about": { "@type": "MedicalCondition", "name": "Névralgie", "code": { "@type": "MedicalCode", "code": "D009437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.612.664" } } }, "about": { "@type": "MedicalCondition", "name": "Algie post-zona", "alternateName": "Neuralgia, Postherpetic", "code": { "@type": "MedicalCode", "code": "D051474", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Song Cao", "url": "https://questionsmedicales.fr/author/Song%20Cao", "affiliation": { "@type": "Organization", "name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Dexin Zhang", "url": "https://questionsmedicales.fr/author/Dexin%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Jie Yuan", "url": "https://questionsmedicales.fr/author/Jie%20Yuan", "affiliation": { "@type": "Organization", "name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Ying Li", "url": "https://questionsmedicales.fr/author/Ying%20Li", "affiliation": { "@type": "Organization", "name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Yuanyuan Ding", "url": "https://questionsmedicales.fr/author/Yuanyuan%20Ding", "affiliation": { "@type": "Organization", "name": "Department of Pain Management, Shengjing Hospital of China Medical University, Shenyang, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Challenges and complications in juvenile localized scleroderma: A practical approach.", "datePublished": "2024-09-17", "url": "https://questionsmedicales.fr/article/39294014", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.berh.2024.101987" } }, { "@type": "ScholarlyArticle", "name": "Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.", "datePublished": "2024-05-24", "url": "https://questionsmedicales.fr/article/38798225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2174/0115734056299155240516102231" } }, { "@type": "ScholarlyArticle", "name": "Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging.", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38415131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21037/qims-23-980" } }, { "@type": "ScholarlyArticle", "name": "[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma].", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36520171", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00393-022-01296-0" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma and scleroderma-like syndromes.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38887288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2024.1351675" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Névralgie", "item": "https://questionsmedicales.fr/mesh/D009437" }, { "@type": "ListItem", "position": 6, "name": "Algie post-zona", "item": "https://questionsmedicales.fr/mesh/D051474" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Algie post-zona - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Algie post-zona", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Algie post-zona", "description": "Comment diagnostique-t-on l'algie post-zona ?\nQuels examens peuvent être réalisés ?\nQuels symptômes indiquent une algie post-zona ?\nPeut-on confondre l'algie post-zona avec d'autres douleurs ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Algie post-zona", "description": "Quels sont les symptômes principaux de l'algie post-zona ?\nLa douleur est-elle constante ou intermittente ?\nY a-t-il des symptômes associés ?\nComment la douleur est-elle décrite par les patients ?\nLes symptômes varient-ils d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Algie post-zona", "description": "Peut-on prévenir l'algie post-zona ?\nQui devrait se faire vacciner contre le zona ?\nY a-t-il des mesures à prendre après une éruption de zona ?\nLa gestion du stress aide-t-elle à prévenir l'algie ?\nLes soins de la peau sont-ils importants après le zona ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Algie post-zona", "description": "Quels traitements sont efficaces contre l'algie post-zona ?\nLes médicaments topiques sont-ils utiles ?\nLa physiothérapie peut-elle aider ?\nY a-t-il des traitements non médicamenteux ?\nLes traitements sont-ils toujours efficaces ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Algie post-zona", "description": "Quelles sont les complications possibles de l'algie post-zona ?\nL'algie post-zona peut-elle affecter la qualité de vie ?\nY a-t-il un risque de dépression avec l'algie post-zona ?\nLes douleurs peuvent-elles s'aggraver avec le temps ?\nDes infections peuvent-elles survenir après le zona ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Algie post-zona", "description": "Quels sont les facteurs de risque de l'algie post-zona ?\nLe stress est-il un facteur de risque ?\nLes personnes atteintes de maladies chroniques sont-elles à risque ?\nLes femmes sont-elles plus à risque que les hommes ?\nL'immunosuppression augmente-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on l'algie post-zona ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et l'examen physique, sans tests spécifiques." } }, { "@type": "Question", "name": "Quels examens peuvent être réalisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes de douleur." } }, { "@type": "Question", "name": "Quels symptômes indiquent une algie post-zona ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une douleur intense, brûlante ou lancinante dans la zone de l'éruption cutanée est typique." } }, { "@type": "Question", "name": "Peut-on confondre l'algie post-zona avec d'autres douleurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres douleurs neuropathiques ou musculo-squelettiques." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique d'une infection par le virus varicelle-zona est crucial pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux de l'algie post-zona ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur intense, hypersensibilité et parfois démangeaisons." } }, { "@type": "Question", "name": "La douleur est-elle constante ou intermittente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La douleur peut être constante ou survenir par épisodes, souvent aggravée par le toucher." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, l'anxiété et des troubles du sommeil peuvent être présents." } }, { "@type": "Question", "name": "Comment la douleur est-elle décrite par les patients ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les patients décrivent souvent la douleur comme brûlante, lancinante ou en coup de poignard." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Peut-on prévenir l'algie post-zona ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination contre le zona peut réduire le risque de développer l'algie post-zona." } }, { "@type": "Question", "name": "Qui devrait se faire vacciner contre le zona ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les adultes de 50 ans et plus sont recommandés pour recevoir le vaccin contre le zona." } }, { "@type": "Question", "name": "Y a-t-il des mesures à prendre après une éruption de zona ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter un médecin rapidement après une éruption pour un traitement précoce." } }, { "@type": "Question", "name": "La gestion du stress aide-t-elle à prévenir l'algie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress peut aider à réduire le risque de douleurs chroniques après le zona." } }, { "@type": "Question", "name": "Les soins de la peau sont-ils importants après le zona ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir la peau propre et hydratée peut aider à prévenir les complications cutanées." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre l'algie post-zona ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des analgésiques, des anticonvulsivants et des antidépresseurs." } }, { "@type": "Question", "name": "Les médicaments topiques sont-ils utiles ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des crèmes anesthésiques peuvent soulager la douleur localement dans certains cas." } }, { "@type": "Question", "name": "La physiothérapie peut-elle aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie peut aider à gérer la douleur et améliorer la fonction dans certains cas." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la thérapie cognitivo-comportementale peuvent être bénéfiques." } }, { "@type": "Question", "name": "Les traitements sont-ils toujours efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité des traitements varie, et certains patients peuvent ne pas répondre aux thérapies." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'algie post-zona ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des douleurs chroniques, des troubles du sommeil et de l'anxiété." } }, { "@type": "Question", "name": "L'algie post-zona peut-elle affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur chronique peut significativement impacter la qualité de vie et le bien-être." } }, { "@type": "Question", "name": "Y a-t-il un risque de dépression avec l'algie post-zona ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur chronique peut augmenter le risque de dépression chez les patients." } }, { "@type": "Question", "name": "Les douleurs peuvent-elles s'aggraver avec le temps ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la douleur peut devenir plus intense et persistante avec le temps." } }, { "@type": "Question", "name": "Des infections peuvent-elles survenir après le zona ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections cutanées peuvent survenir si la peau est lésée pendant l'éruption." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'algie post-zona ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, un système immunitaire affaibli et des antécédents de zona." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'algie post-zona." } }, { "@type": "Question", "name": "Les personnes atteintes de maladies chroniques sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques peuvent augmenter le risque de développer l'algie post-zona." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque que les hommes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que les femmes peuvent être légèrement plus à risque que les hommes." } }, { "@type": "Question", "name": "L'immunosuppression augmente-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunosupprimées ont un risque accru de développer l'algie post-zona." } } ] } ] }

Sources (10000 au total)

Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.

Although clinical assessment has historically been the primary method used for pediatric localized sclerosis (LS) diagnosis and staging, highfrequency ultrasonography (HFUS) is being investigated as a... This study aimed to assess, compare dermal and subcutaneous tissue characteristics and enhance enhance lesion staging in pediatric LS patients using HFUS.... Twenty two LS patients were cross-sectionally evaluated with B-mode ultrasonography. Lesions were clinically staged, and dermal and subcutaneous tissue characteristics were compared with healthy tissu... Among 55 lesions, 27 were active/new (49.1%), and 28 were atrophic/old (50.9%). Active lesions typically had increased dermal thickness in 66.6% of cases, while atrophic lesions often showed decreased... Ultrasonography offers an objective LS lesion evaluation, especially in pediatrics....

Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging.

Localized scleroderma (LoS) is an autoimmune disease in which craniofacial lesions can cause severe facial deformities with brain involvement. Objective evaluation of craniofacial LoS is challenging. ... This cross-sectional study included patients with craniofacial LoS from September 2021 to August 2022 in Peking Union Medical College Hospital. Patients who were clinically assessed in a stable phase ... A total of 28 patients were included (13 female; mean age, 18 years). MRI showed a good correlation and agreement with ultrasound (r=0.916, P<0.001). In different facial subunits, a significant negati... MRI can reliably quantify damage in craniofacial LoS, and may serve as a useful and objective tool for overall craniofacial LoS evaluation....

[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma].

Localized scleroderma is an autoimmune disease belonging to the group of collagenoses, which can manifest cutaneously and extracutaneously. The extracutaneous manifestations may have significant morbi... In the retrospective monocentric study at the Hamburg Center for Pediatric and Adolescent Rheumatology, the TMS was applied to patients from 2004-2019 suffering from localized scleroderma who had at l... Due to a lack of control presentations, data from 51 of the 95 patients with a confirmed diagnosis could be included in the retrospective evaluation. The treatment of these patients was considered ove... The evaluation showed that the TMS total score is mainly fed by the extracutaneous manifestations, demonstrating the inaccuracy of previous scores. Another advantage of the TMS is that different score...

Case Report: Exacerbation after fat grafting in patients with active localized scleroderma.

The application of autologous fat transplantation in facial lesions of patients with localized scleroderma (LoS) has been reported in recent years.... The authors report a case of worsening of active localized scleroderma after autologous fat transplantation.... A man presented with neck and facial skin atrophy and pigmentation with a history of LoS. Appearing 1.5 years ago, the lesion had progressively grown in size and shape. Consent was obtained after the ... Skin dyspigmentation and atrophy progressively deteriorated 1 month into therapy, with slightly increased erythema and enlargement of the lesion. Six months after the therapy, the localized scleroderm... There are different factors, such as that systemic medications could affect the treatment of localized scleroderma by autologous fat transplantation. Meanwhile, considering the limitation of the 6-mon... More clinical research is needed to determine the time interval between disease inactivity and the application of any surgical procedures to avoid reactivation....